Government, leadership and policy: latest news

Government, leadership and policy features

Government, leadership and policy news from aidsmap

More news

Government, leadership and policy news selected from other sources

  • UNAIDS, UNICEF and WHO urge countries in western and central Africa to step up the pace in the response to HIV for children and adolescents

    At a high-level meeting in Dakar, Senegal, UNAIDS, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) urged countries in western and central Africa to do more to stop new HIV infections among children and adolescents and increase HIV testing and treatment coverage. 

    16 hours ago | UNAIDS press release
  • William Barr, Trump's Pick For DOJ, Ran 'HIV Camps' At Guantanamo

    The Daily Beast just dropped the story that decades ago William Barr President Donald Trump’s pick to take over the reigns at Department of Justice used his past post “to indefinitely detain hundreds of HIV-positive asylum-seekers at a Guantanamo Bay detention center, deemed an ‘HIV prison camp’ by a federal judge who ruled the quarantine to be in gross violation of the U.S. Constitution.” This is just the tip of the iceberg for Barr’s criticism by LGBTQ politicians and organizations.

    17 hours ago | Towleroad
  • Delving into community health and HIV in Brazil

    Michael Touchton’s groundbreaking study, “Community Health Governance and HIV in Brazil,” is the first time there has been a large, comprehensive scholarly analysis of the effects of participatory democratic institutions and social policies on public health and how this can affect conditions and the capacity to deliver health services.

    11 January 2019 | University of Miami
  • DFID needs to keep pushing on AIDS, says HIV-positive MP

    The United Kingdom’s aid department must put more resources into fighting HIV/AIDS or risk seeing global progress backslide, according to politician Lloyd Russell-Moyle, who stood up in the House of Commons and revealed he was HIV positive late last year.

    11 January 2019 | Devex
  • UK-CAB statement on Brexit, HIV and access to medicines

    On 19 December 2018, the UK-CAB, an HIV treatment advocacy organisation, published recommendations to mimimise the risk for HIV positive people having an interruption in supply of medicines, due to uncertainty over plans for Brexit.

    20 December 2018 | UK-CAB
  • China’s history with AIDS explains a puzzling aspect of the ‘CRISPR babies’ story

    The first time I met someone in China dying from complications of AIDS, he had never heard of the illness that had already killed thousands of his fellow citizens. That ignorance among sufferers, in parts of the country where people were most likely to have it, reflected China’s unique and complex history with AIDS, one that involved a litany of scandals and government cover-ups that have left a lasting imprint of stigma and fear about HIV and AIDS — and discrimination.

    17 December 2018 | STAT
  • Statement From Ambassador Deborah L. Birx, M.D., on President Trump Signing PEPFAR Extension Act of 2018

    President Donald J. Trump signed yesterday the PEPFAR Extension Act of 2018, which extends provisions of the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 for an additional five years.

    13 December 2018 | PEPFAR
  • Two Cochairs Named for Presidential Advisory Council on HIV/AIDS

    Last year, six members of PACHA resigned in protest of Trump, who then fired the rest. Until now, the council had remained empty.

    13 December 2018 | Poz
  • Trump quietly shuts down HIV cure research to appease the religious right

    Scientists are speaking out against a directive by the Trump administration that has shut down research into a cure for HIV. A scientist who was supposed to supply mice that have been modified with human fetal tissue for an HIV study emailed researchers that the Department of Health and Human Services (HHS) “has directed me to discontinue procuring fetal tissue.”

    12 December 2018 | LGBTQ Nation
  • HIV 2020 - Community Reclaiming the Global Response

    An alliance of global key population-led networks, networks of people living with HIV, treatment activists, and our supporters, has formed to organize an alternative international community-led event. Titled, HIV2020: Community Reclaiming the Global Response, the event is scheduled to take place in Mexico City, July 6-8, 2020, and will run concurrently with the first half of the international AIDS conference. The HIV2020 alliance has decided to organize the community-led event to provide a safe alternative for individuals who cannot or will not enter the U.S. in 2020 or who cannot afford to attend AIDS2020. It will also offer new opportunities to reaffirm the leading role communities play in the global HIV response.

    10 December 2018 |
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.